KDM1A and neoplasm: Guided by our in vitro data, we assessed the in vivo effects of LSD1 inhibition in orthotopic xenograft models of MDA-GSCs and observed a significant drop in tumor burden after long-term treatment with the LSD1 inhibitor, GSK-LSD1, which was transient with tumor regrowth occurring.